Literature DB >> 10400924

The CMT2D locus: refined genetic position and construction of a bacterial clone-based physical map.

R E Ellsworth1, V Ionasescu, C Searby, V C Sheffield, V V Braden, T A Kucaba, J D McPherson, M A Marra, E D Green.   

Abstract

Charcot-Marie-Tooth (CMT) disease is a progressive neuropathy of the peripheral nervous system, typically characterized by muscle weakness of the distal limbs. CMT is noted for its genetic heterogeneity, with four distinct loci already identified for the axonal form of the disease (CMT2). In 1996, linkage analysis of a single large family revealed the presence of a CMT2 locus on chromosome 7p14 (designated CMT2D). Additional families have been linked subsequently to the same genomic region, including one with distal spinal muscular atrophy (dSMA) and one with mixed features of dSMA and CMT2; symptoms in both of these latter families closely resemble those seen in the original CMT2D family. There is thus a distinct possibility that CMT2 and dSMA encountered in these families reflect allelic heterogeneity at a single chromosome 7 locus. In the study reported here, we have performed more detailed linkage analysis of the original CMT2D family based on new knowledge of the physical locations of various genetic markers. The region containing the CMT2D gene, as defined by the original family, overlaps with those defined by at least two other families with CMT2 and/or dSMA symptoms. Both yeast artificial chromosome (YAC) and bacterial clone-based [bacterial artificial chromosome (BAC) and P1-derived artificial chromosome (PAC)] contig maps spanning approximately 3.4 Mb have been assembled across the combined CMT2D critical region, with the latter providing suitable clones for systematic sequencing of the interval. Preliminary analyses have already revealed at least 28 candidate genes and expressed-sequence tags (ESTs). The mapping information reported here in conjunction with the evolving sequence data should expedite the identification of the CMT2D/dSMA gene or genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400924      PMCID: PMC310773     

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  18 in total

1.  A physical map of human chromosome 7: an integrated YAC contig map with average STS spacing of 79 kb.

Authors:  G G Bouffard; J R Idol; V V Braden; L M Iyer; A F Cunningham; L A Weintraub; J W Touchman; R M Mohr-Tidwell; D C Peluso; R S Fulton; M S Ueltzen; J Weissenbach; C L Magness; E D Green
Journal:  Genome Res       Date:  1997-07       Impact factor: 9.043

2.  OSP: a computer program for choosing PCR and DNA sequencing primers.

Authors:  L Hillier; P Green
Journal:  PCR Methods Appl       Date:  1991-11

Review 3.  A gene map of the human genome.

Authors:  G D Schuler; M S Boguski; E A Stewart; L D Stein; G Gyapay; K Rice; R E White; P Rodriguez-Tomé; A Aggarwal; E Bajorek; S Bentolila; B B Birren; A Butler; A B Castle; N Chiannilkulchai; A Chu; C Clee; S Cowles; P J Day; T Dibling; N Drouot; I Dunham; S Duprat; C East; C Edwards; J B Fan; N Fang; C Fizames; C Garrett; L Green; D Hadley; M Harris; P Harrison; S Brady; A Hicks; E Holloway; L Hui; S Hussain; C Louis-Dit-Sully; J Ma; A MacGilvery; C Mader; A Maratukulam; T C Matise; K B McKusick; J Morissette; A Mungall; D Muselet; H C Nusbaum; D C Page; A Peck; S Perkins; M Piercy; F Qin; J Quackenbush; S Ranby; T Reif; S Rozen; C Sanders; X She; J Silva; D K Slonim; C Soderlund; W L Sun; P Tabar; T Thangarajah; N Vega-Czarny; D Vollrath; S Voyticky; T Wilmer; X Wu; M D Adams; C Auffray; N A Walter; R Brandon; A Dehejia; P N Goodfellow; R Houlgatte; J R Hudson; S E Ide; K R Iorio; W Y Lee; N Seki; T Nagase; K Ishikawa; N Nomura; C Phillips; M H Polymeropoulos; M Sandusky; K Schmitt; R Berry; K Swanson; R Torres; J C Venter; J M Sikela; J S Beckmann; J Weissenbach; R M Myers; D R Cox; M R James; D Bentley; P Deloukas; E S Lander; T J Hudson
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

4.  A collection of 1814 human chromosome 7-specific STSs.

Authors:  G G Bouffard; L M Iyer; J R Idol; V V Braden; A F Cunningham; L A Weintraub; R M Mohr-Tidwell; D C Peluso; R S Fulton; M P Leckie; E D Green
Journal:  Genome Res       Date:  1997-01       Impact factor: 9.043

5.  End sequence determination from large insert clones using energy transfer fluorescent primers.

Authors:  M Marra; L A Weinstock; E R Mardis
Journal:  Genome Res       Date:  1996-11       Impact factor: 9.043

6.  Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D).

Authors:  V Ionasescu; C Searby; V C Sheffield; T Roklina; D Nishimura; R Ionasescu
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

7.  Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p.

Authors:  K Christodoulou; T Kyriakides; A H Hristova; D M Georgiou; L Kalaydjieva; B Yshpekova; T Ivanova; J L Weber; L T Middleton
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

Review 8.  Charcot-Marie-Tooth disease and related inherited neuropathies.

Authors:  T Murakami; C A Garcia; L T Reiter; J R Lupski
Journal:  Medicine (Baltimore)       Date:  1996-09       Impact factor: 1.889

9.  Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity.

Authors:  K Ben Othmane; L T Middleton; L J Loprest; K M Wilkinson; F Lennon; M P Rozear; J M Stajich; P C Gaskell; A D Roses; M A Pericak-Vance
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

10.  Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.

Authors:  J M Kwon; J L Elliott; W C Yee; J Ivanovich; N J Scavarda; P J Moolsintong; P J Goodfellow
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

View more
  6 in total

1.  Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

Authors:  R E Ellsworth; D C Jamison; J W Touchman; S L Chissoe; V V Braden Maduro; G G Bouffard; N L Dietrich; S M Beckstrom-Sternberg; L M Iyer; L A Weintraub; M Cotton; L Courtney; J Edwards; R Maupin; P Ozersky; T Rohlfing; P Wohldmann; T Miner; K Kemp; J Kramer; I Korf; K Pepin; L Antonacci-Fulton; R S Fulton; P Minx; L W Hillier; R K Wilson; R H Waterston; W Miller; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.

Authors:  Stephanie N Oprescu; Laurie B Griffin; Asim A Beg; Anthony Antonellis
Journal:  Methods       Date:  2016-11-20       Impact factor: 3.608

3.  The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.

Authors:  J W Touchman; Y Anikster; N L Dietrich; V V Maduro; G McDowell; V Shotelersuk; G G Bouffard; S M Beckstrom-Sternberg; W A Gahl; E D Green
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

Review 4.  The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy.

Authors:  Cornelius F Boerkoel; Hiroshi Takashima; James R Lupski
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

5.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Authors:  Anthony Antonellis; Rachel E Ellsworth; Nyamkhishig Sambuughin; Imke Puls; Annette Abel; Shih-Queen Lee-Lin; Albena Jordanova; Ivo Kremensky; Kyproula Christodoulou; Lefkos T Middleton; Kumaraswamy Sivakumar; Victor Ionasescu; Benoit Funalot; Jeffery M Vance; Lev G Goldfarb; Kenneth H Fischbeck; Eric D Green
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

6.  Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.

Authors:  Laurie B Griffin; Reiko Sakaguchi; David McGuigan; Michael A Gonzalez; Charles Searby; Stephan Züchner; Ya-Ming Hou; Anthony Antonellis
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.